Gain Therapeutics Net Profit Margin Growth & History (GANX)
Gain Therapeutics's net profit margin was −40,354.33% for fiscal 2023.
View full Gain Therapeutics company overviewGain Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −40,354.33% | −27092.32 pp |
| 2022 | 2022-12-31 | −13,262.02% | −2890.32 pp |
| 2021 | 2021-12-31 | −10,371.70% | +2015.97 pp |
| 2020 | 2020-12-31 | −12,387.67% | — |
Gain Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2023 | 2023-03-31 | −9,310.11% | −591.90 pp |
| Q2 2022 | 2022-06-30 | −5,347.33% | −989.55 pp |
| Q1 2022 | 2022-03-31 | −8,718.21% | +37788.66 pp |
| Q4 2021 | 2021-12-31 | −10,363.15% | +7753.51 pp |
| Q3 2021 | 2021-09-30 | −29,200.01% | −17336.64 pp |
| Q2 2021 | 2021-06-30 | −4,357.78% | +4168.22 pp |
| Q1 2021 | 2021-03-31 | −46,506.87% | −37751.17 pp |
| Q4 2020 | 2020-12-31 | −18,116.65% | — |
| Q3 2020 | 2020-09-30 | −11,863.37% | — |
| Q2 2020 | 2020-06-30 | −8,526.00% | — |
| Q1 2020 | 2020-03-31 | −8,755.70% | — |
Gain Therapeutics net profit margin trends
Between the periods ended 2020-12-31 and 2023-12-31, Gain Therapeutics's net profit margin decreased from −12,387.67% to −40,354.33%, a change of −27966.66 percentage points. The latest reported quarter, Q1 2023, shows −9,310.11%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gain Therapeutics source filings ↗